Direct Answer
This timeline highlights milestones that shaped Gilead Sciences, Inc. (GILD)'s business model, competitive position, and investment thesis.
Key Milestones
| Year | Milestone |
|---|---|
| 1987 | Gilead was founded as a biotechnology company focused on antiviral science. |
| 1990s-2000s | The company built a major antiviral franchise through internal development, partnerships, and acquisitions. |
| 2011 | Gilead agreed to acquire Pharmasset, a pivotal step in the hepatitis C franchise that later transformed the company's earnings base. |
| 2017 | Gilead acquired Kite Pharma, establishing a cell-therapy platform in oncology. |
| 2020s | The company has continued to defend and expand its HIV franchise while investing heavily in oncology and other pipeline opportunities. |
Why the Chronology Matters
The timeline should emphasize events that changed the business model, segment comparability, competitive position, capital structure, or investment thesis. Link major acquisitions, divestitures, regulatory events, and platform transitions to dedicated Swoopr case studies where available.
Frequently Asked Questions
What are the most important milestones in Gilead Sciences, Inc.'s history?
The most significant milestones for Gilead Sciences, Inc. are those that changed the business model, created or disrupted a competitive advantage, altered segment comparability, or reset the investment thesis.
Why does the company timeline matter for Gilead Sciences, Inc. investors?
The Gilead Sciences, Inc. timeline matters because it explains how the current business model was constructed. Understanding when key decisions were made helps investors assess which competitive advantages are durable.
How has Gilead Sciences, Inc.'s business model evolved over time?
Gilead Sciences, Inc.'s business model has evolved through product transitions, market expansions, and strategic decisions. Each major transition changed revenue mix, margin structure, and capital requirements.